* iRhythm Technologies Inc IRTC.OQ reported a quarterly
adjusted
loss of 4 cents per share for the quarter ended December 31,
higher than the same quarter last year, when the company
reported EPS of $-1.26. The mean expectation of
thirteen analysts for the quarter was for a loss of 25 cents per
share. Wall Street expected results to range from -52 cents
to -3 cents per share.
* Revenue rose 24% to $164.33 million from a year ago;
analysts
expected $157.94 million.
* iRhythm Technologies Inc's reported EPS for the quarter
was a
loss of 4 cents.
* The company reported a quarterly loss of $1.33 million.
* iRhythm Technologies Inc shares had risen by 25.4% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 12.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for iRhythm
Technologies Inc is $108.00
This summary was machine generated from LSEG data February 20 at
10:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.25 -0.04 Beat
Sep. 30 2024 -0.57 -1.26 Missed
Jun. 30 2024 -0.89 -0.61 Beat
Mar. 31 2024 -0.96 -1.23 Missed